Price Alert

Imunon Inc. (CLSN)

NASDAQ: CLSN · Real-Time Price · USD

1.95

-0.01 (-0.51%)

At close: Sep 21, 2022, 6:00 AM

Imunon Statistics

Share Statistics

Imunon has 7.43M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	7.43M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	7.34M
Failed to Deliver (FTD) Shares	n/a
FTD / Avg. Volume	n/a

Short Selling Information

The latest short interest is 75.34K, so 0% of the outstanding shares have been sold short.

Short Interest	75.34K
Short % of Shares Out	n/a
Short % of Float	1.07%
Short Ratio (days to cover)	1.83

Valuation Ratios

PE Ratio	0
Forward PE	n/a
PS Ratio	0
Forward PS	n/a
PB Ratio	0.01
P/FCF Ratio	0
PEG Ratio	0

Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Imunon.

EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	0
Quick Ratio	0
Debt / Equity	0.27
Debt / EBITDA	-0.06
Debt / FCF	-0.06
Interest Coverage	0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity	n/a
Return on Assets	n/a
Return on Invested Capital	n/a
Revenue Per Employee	n/a
Profits Per Employee	$-642.08M
Employee Count	29
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	0%

Stock Price Statistics

The stock price has increased by null% in the last 52 weeks. The beta is 2.26, so Imunon's price volatility has been higher than the market average.

Beta	2.26
52-Week Price Change	n/a
50-Day Moving Average	2.23
200-Day Moving Average	n/a
Relative Strength Index (RSI)	36.16
Average Volume (20 Days)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-19.13B
Net Income	-18.62B
EBITDA	-19.13B
EBIT	n/a
Earnings Per Share (EPS)	-1.62

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	n/a
Total Debt	1.14B
Net Cash	n/a
Retained Earnings	-406.8B
Total Assets	65.33M
Working Capital	38.02M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -18.85B and capital expenditures -29.54M, giving a free cash flow of -18.88B.

Operating Cash Flow	-18.85B
Capital Expenditures	-29.54M
Free Cash Flow	-18.88B
FCF Per Share	-1640.99

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CLSN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Analyst Forecast

Currently there are no analyst rating for CLSN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on Mar 1, 2022. It was a backward split with a ratio of 1:15.

Last Split Date	Mar 1, 2022
Split Type	backward
Split Ratio	1:15

Scores

Altman Z-Score	-7.38
Piotroski F-Score	2